Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
7.85
+1.67 (27.02%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $25.18 million as of April 1, 2026. Its market cap has increased by 4.97% in one year.
Market Cap
25.18M
Enterprise Value
2.89M
1-Year Change
4.97%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $25.18M, a decrease of -97.37%. That is a compound annual growth rate of -44.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 19.82M | -47.15% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 22.51M |
| Vistagen Therapeutics | 22.49M |
| Cue Biopharma | 22.34M |
| Outlook Therapeutics | 22.17M |
| Curis | 21.76M |
| Tempest Therapeutics | 21.50M |
| Neuphoria Therapeutics | 21.35M |
| Senti Biosciences | 20.64M |